Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

ClinicalTrials.gov ID: NCT00665782

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00665782. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Stress Measures in Women With Newly Diagnosed Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Gathering information about how patients respond to stress and measuring stress levels in women with newly diagnosed breast cancer may help doctors provide better methods of treatment and on-going care. PURPOSE: This research study is measuring stress in women with newly diagnosed stage I, stage II, or stage III breast cancer or ductal carcinoma in situ of the breast.

Study identification

NCT ID: NCT00665782
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Enrollment: 24 participants

Conditions and interventions

Conditions

Interventions

laboratory biomarker analysis Other
questionnaire administration Other
study of socioeconomic and demographic variables Other
assessment of therapy complications Procedure
psychosocial assessment and care Procedure
therapeutic conventional surgery Procedure

Other · Procedure

Eligibility (public fields only)

Age range: 18 Years to 120 Years
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 2008 (Type not available)
Primary completion: Jul 2010 (Actual)
Completion: Jul 2010 (Actual)
Last update posted: Jul 3, 2018

2008 – 2010

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Wake Forest University Comprehensive Cancer Center	Winston-Salem	North Carolina	27157-1096	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00665782, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 3, 2018 · Synced Nov 15, 2026